Mixed Results for Hospital-Based Smoking Cessation Program
Hospital-based transitional tobacco care management was no better than referral to a…
Browsing Tag
Cessation
Smoking cessation through a healthcare system model is shown more effective than…
A healthcare system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three- month program…
U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment…
Cessation Program in Cancer Clinics May Reach More Tobacco Smokers
Physician’s Briefing Staff
FRIDAY, May 13, 2022 (HealthDay News) -- A low-burden point-of-care intervention, featuring an electronic health…
Achieve Life Sciences Announces Successful, Statistically Significant Smoking…
Clinically robust and statistically significant results in primary and secondary endpoints for both 6- and 12-week cytisinicline treatment compared to placebo Primary endpoints…
E-Cig Cessation for Teens; COVID and Neurological Events
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for…
Tigray rebels commit to ‘cessation of hostilities’ after Ethiopia’s truce…
Issued on: 25/03/2022 - 08:34Modified: 25/03/2022 - 08:36
Tigrayan rebels agreed to a “cessation of hostilities” on Friday,…
Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study
DENVER, March 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology company aiming to transform…
Score One for Vapes in Smoking Cessation
Some smokers who said they had no plans to quit ended up doing so after taking up e-cigarettes,…
Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to…
SEATTLE and VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global…